TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.

Robert Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.